Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 14, 2026; 32(46): 123696
Published online Dec 14, 2026. doi: 10.3748/wjg.123696
Published online Dec 14, 2026. doi: 10.3748/wjg.123696
Figure 2 Trans-3-indoleacrylic acid preserves intestinal barrier integrity and reduces intestinal permeability in mice with colitis.
A: Fluorescence intensity of fluorescein isothiocyanate-dextran in serum; B-D: Relative mRNA expression of Tjp1, Ocln, and Cldn1 in colonic tissues; E-G: Representative immunoblots and the relative protein expression of ZO-1 and Occludin in colonic tissues; H: Representative images of colonic sections stained with alcian blue-periodic acid-Schiff (scale bars = 50 μm); I: Number of goblet cells. The data are shown as the mean ± SD (n = 6 mice per group). Group comparisons were analyzed using one-way ANOVA with Sidak’s multiple comparisons test. aP < 0.01, bP < 0.001, cP < 0.0001. DSS: Dextran sulfate sodium; IDA: Trans-3-indoleacrylic acid; FITC-Dextran: Fluorescein isothiocyanate-Dextran; AB-PAS: Alcian blue-periodic acid-Schiff.
- Citation: Tuo JW, Wu X, Shen ZH, Wang XY. Trans-3-indoleacrylic acid ameliorates dextran sulfate sodium-induced colitis by modulating macrophage M1 polarization through the aryl hydrocarbon receptor pathway. World J Gastroenterol 2026; 32(46): 123696
- URL: https://www.wjgnet.com/1007-9327/full/v32/i46/123696.htm
- DOI: https://dx.doi.org/10.3748/wjg.123696